logo

GYRE

Gyre Therapeutics
--
--(--)
Market Open: --
--
--(--)
Post-Market: --

GYRE Profile

Gyre Therapeutics, Inc.

A biopharmaceutical company committed to the research, development, manufacturing and commercialization of innovative drugs for the treatment of organ fibrosis

Pharmaceutical
Invalid Date
04/12/2006
NASDAQ Stock Exchange
5
12-31
Common stock
12730 High Bluff Drive, Suite 150, San Diego, CA 92130
--
Gyre Therapeutics, Inc., is incorporated in Delaware. The Company and its subsidiaries are a biopharmaceutical company dedicated to the research, development, manufacture and commercialization of innovative medicines for the treatment of organ fibrosis.